⚠ FOR RESEARCH USE ONLY
Selank

CHEMICAL PROPERTIES

CAS NUMBER129954-34-3
MOLECULAR WEIGHT751.86 g/mol
MOLECULAR FORMULAC₃₃H₅₇N₁₁O₉

PHYSICAL PROPERTIES

APPEARANCEWhite lyophilized powder in sealed borosilicate glass vial.
SEQUENCEThr-Lys-Pro-Arg-Pro-Gly-Pro
Neuro Research

Selank

Selank is a synthetic heptapeptide and stabilized analogue of the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg). The additional Pro-Gly-Pro sequence significantly enhances metabolic stability, extending its biological activity window for research applications.

1
Free shipping on orders over $150
2-day delivery
LOT NUMBERLMO-0626-SEL-018
REPORT NO.RPT-20012
HPLC PURITY98.55%

7× Independently Tested

HPLC PurityIndependent lab
IdentitySequence confirmed
Net ContentExact mg verified
SterilityContamination-free
EndotoxinsLAL tested
Heavy MetalsICP-MS screened
Batch ConsistencyLot-to-lot stability
7×
TESTED
⚠

RESEARCH USE ONLY

This compound is sold strictly for in vitro research and laboratory use. Not for human or animal consumption. Not a drug, food, or supplement. By purchasing you confirm you are a qualified researcher and will use this compound in compliance with all applicable laws. Must be 21 or older.

RESEARCH

Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank in the Therapy of Generalised Anxiety Disorders and Neurasthenia
Semenova TP, Kozlovskiy II, Zakharova NM, Kozlovskaya MM. · Experimental and Clinical Pharmacology · 2008
Reports Phase III clinical trial data in anxiety disorders and neurasthenia, demonstrating anxiolytic efficacy of Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) comparable to benzodiazepines with superior tolerability.
PMID 19093364
Intranasal Administration of the Peptide Selank Regulates BDNF Expression in the Rat Hippocampus In Vivo
Inozemtseva LS, Karpenko EA, Dolotov OV, et al. · Doklady Biological Sciences · 2008
Demonstrates that intranasal Selank elevates hippocampal BDNF expression in vivo, providing a neurotrophin-based mechanism for its cognitive and anxiolytic effects.
PMID 18841804
Experimental Optimisation of Learning and Memory Processes by Selank
Semenova TP, Kozlovskiy II, Zakharova NM, Kozlovskaya MM. · Experimental and Clinical Pharmacology · 2010
Reports improvements in spatial learning and memory consolidation metrics in rodent models following Selank administration, supporting its nootropic research profile.
PMID 20919548

LAB RESULTS

LOT LMO-0626-SEL-018 · CURRENT

Certificate of Analysis

PURITY
98.55%
CAS
129954-34-3
MW
751.86 g/mol
APPEARANCE
White lyophilized powder in sealed borosilicate glass vial.
VERIFIED

Third-Party Report

TESTING LABIndependent Analytics LLC
TEST DATEJanuary 2025
METHODS USED
HPLCMSAAA
RESEARCH APPLICATIONS

What the literature covers.

  • ●GABA-A receptor modulation and anxiolytic mechanism studies
  • ●BDNF and NGF expression profiling in neuronal cell culture models
  • ●Tuftsin analogue receptor binding and metabolic stability comparison
  • ●Immunomodulatory effects research in T-cell and macrophage models

All compounds sold by Lumo are intended strictly for in vitro research and laboratory use only. These products are NOT intended for human consumption, medical, veterinary, or household use. By purchasing from Lumo, you acknowledge that you are a qualified researcher or institution and will use these products solely for research purposes in compliance with all applicable laws and regulations.

L-003

Stay current.

New lot releases, research updates, and product announcements.

Unsubscribe anytime. Research use communications only.

Research Use Only · Not for Human Consumption · For Laboratory Research Purposes Only

Your Cart

● All items for research use only. Not for human consumption.
●

Your cart is empty

Add compounds to get started